The differential antiviral activities of chicken interferon α (ChIFN-α) and ChIFN-β are related to distinct interferon-stimulated gene expression

PLoS One. 2013;8(3):e59307. doi: 10.1371/journal.pone.0059307. Epub 2013 Mar 19.

Abstract

Chicken interferon α (ChIFN-α) and ChIFN-β are type I IFNs that are important antiviral cytokines in the innate immune system. In the present study, we identified the virus-induced expression of ChIFN-α and ChIFN-β in chicken fibroblast DF-1 cells and systematically evaluated the antiviral activities of recombinant ChIFN-α and ChIFN-β by cytopathic-effect (CPE) inhibition assays. We found that ChIFN-α exhibited stronger antiviral activity than ChIFN-β in terms of inhibiting the replication of vesicular stomatitis virus, Newcastle disease virus and avian influenza virus, respectively. To elucidate the mechanism of differential antiviral activities between the two ChIFNs, we measured the relative mRNA levels of IFN-stimulated genes (ISGs) in IFN-treated DF-1 cells by real-time PCR. ChIFN-α displayed greater induction potency than ChIFN-β on several ISGs encoding antiviral proteins and MHC-I, whereas ChIFN-α was less potent than ChIFN-β for inducing ISGs involved in signaling pathways. In conclusion, ChIFN-α and ChIFN-β presented differential induction potency on various sets of ISGs, and the stronger antiviral activity of ChIFN-α is likely attributed to the greater expression levels of downstream antiviral ISGs.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Base Sequence
  • Cattle
  • Cell Line
  • Chickens / immunology*
  • Chromatography, Gel
  • Escherichia coli
  • Fibroblasts
  • Gene Expression Regulation / immunology*
  • Immunity, Innate / immunology*
  • Influenza A Virus, H9N2 Subtype / drug effects
  • Interferon-alpha / chemistry
  • Interferon-alpha / genetics
  • Interferon-alpha / immunology*
  • Interferon-alpha / pharmacology
  • Interferon-beta / chemistry
  • Interferon-beta / genetics
  • Interferon-beta / immunology*
  • Interferon-beta / pharmacology
  • Models, Molecular*
  • Molecular Sequence Data
  • Mutagenesis, Site-Directed
  • Newcastle disease virus / drug effects
  • Sequence Alignment
  • Sequence Analysis, DNA
  • Vesiculovirus / drug effects

Substances

  • Interferon-alpha
  • Interferon-beta

Grants and funding

This study was funded by the National Natural Science Foundation of China (NSFC) (www.nsfc.gov.cn, Grant No. 31100644), the Ministry of Science and Technology program of China (www.most.gov.cn, Grant No. 2011AA10A215, 2010GB24910698). Wenjun Liu is a principal investigator of the National Natural Science Foundation of China Innovative Research Group (www.nsfc.gov.cn, Grant No. 81021003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.